Journal of the korean academy of Pediatric Dentistry (대한소아치과학회지)

Korean Academy of Pediatric Dentistry (대한소아치과학회)
권호 표지
DOI QR코드

DOI QR Code

EFFECT OF SUPPLEMENTARY INTRANASAL MIDAZOLAM ON ORAL SEDATION OF CHILDREN

미다졸람의 비강 내 추가투여가 소아의 경구 진정요법에 미치는 영향

  • Jang, Su-Young (Department of Pediatric Dentistry, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Ji-Yeon (Department of Pediatric Dentistry, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Ki-Tae (Department of Pediatric Dentistry, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 장수영 (성균관대학교 의과대학 삼성서울병원 치과진료부 소아치과) ;
  • 김지연 (성균관대학교 의과대학 삼성서울병원 치과진료부 소아치과) ;
  • 박기태 (성균관대학교 의과대학 삼성서울병원 치과진료부 소아치과)
  • Received : 2011.08.31
  • Accepted : 2012.01.10
  • Published : 2012.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

Effect of supplementary intranasal midazolam on oral sedation of children The purpose of this study was to compare the cardiopulmonary parameters of two sedation regimens during dental treatment: (1) Oral chloral hydrate(CH) and hydroxyzine(HZ) with nitrous oxide-oxygen($N_2O/O_2$) inhalation(CH-HZ group); (2) Oral chloral hydrate(CH) and hydroxyzine(HZ) with nitrous oxide-oxygen($N_2O/O_2$) inhalation and supplementary intranasal(IN) midazolam administration(MIDA group). Among the patients of OO hospital who received dental treatment under sedation over the past 5 years, 44 patients were selected for each group of CH-HZ and MIDA according to their age, gender and weight. Following parameters that were recorded every 5 minutes were compared: 1) Heart rate(HR) 2) $O_2$ saturation 3) End tidal carbon dioxide concentration($EtCO_2$) 4) Respiratory rate(RR) 33 patients of Group MIDA who have complete data of 15 minutes before and after supplementary IN midazolam administration were selected. And measurements 15 minutes before and after midazolam administration in same patient were evaluated. The results were as follows: 1. Heart rate was significantly higher in MIDA group than in CH-HZ group, but it was within normal range. 2. Comparing HR, $O_2$ saturation, EtCO2, RR between before and after of supplementary IN midazolam administration in the same patient, the differences were not statistically significant.

이 연구는 소아환자의 경구 진정요법 시 미다졸람의 비강 내 추가 투여가 심폐기능에 미치는 영향을 알아보기 위한 것으로 5 년간 삼성서울병원 소아치과에서 chloral hydrate와 hydroxyzine을 경구투여하고 $N_2O/O_2$ inhalation을 추가로 사용한 진정요법으로 치료 받은 환자 중 미다졸람을 추가투여 받은 실험군(MIDA군)과, 미다졸람을 추가 투여하지 않은 대조군 (CH-HZ군)을 각각 44명씩 선정하여 서로 비교하였다. 진정요법 중 5분마다 측정된 1) Heart rate(HR) 2) $O_2$ saturation 3) End tidal carbon dioxide concentration ($EtCO_2$), 4) Respiratory rate(RR)의 평균값을 비교하였다. 또한 동일 환자에서의 미다졸람 투여 전 후의 심폐기능지표의 변화 양상을 평가하기 위해 MIDA군 중에서 미다졸람 투여 전 후 15분 이상의 기록이 존재하는 33명을 선정하여 미다졸람 투여 전 후 15분 시점의 측정값을 각각 비교하였다. 결과는 다음과 같다. 1. Heart rate는 미다졸람을 추가 투여한 군에서 유의하게 높았으며 나머지 심폐기능 지표의 측정값들은 차이가 없었다. 두 군의 측정값들은 모두 정상범위 안에 있었다. 2. 동일 환자에서 미다졸람 투여 전 후 15분의 측정값을 비교한 결과 두 시점간에 측정된 값들은 유의한 차이가 없었다.

Keywords

References

  1. 대한소아치과학회: 소아.청소년치과학, 4판, 신흥 인터내셔날, 서울, 248-275, 2007.
  2. 안소연, 최병재, 곽지윤 등: 어린이의 치과치료시 약물에 의한 진정요법 사용에 대한 실태조사. 대한소아치과학회지, 32:444-453, 2005.
  3. Saint-Maurice C, Meistelman C, Rey E, et al. : The pharmacokinetics of rectal midazolam for premedication in children. Anesthesiology, 65:536-538, 1986. https://doi.org/10.1097/00000542-198611000-00019
  4. Payne K, Mattheyse FJ, Liebenberg D, Dawes T: The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol, 37:267-272, 1989. https://doi.org/10.1007/BF00679782
  5. Myers GR, Maestrello CL, Mourino AP, Best AM: Effect of submucosal midazolam on behavior and physiologic response when combined with oral chloral hydrate and nitrous oxide sedation. Pediatr Dent, 26:37-43, 2004.
  6. 이영은, 박미경, 김윤희 등: 소아 진정시 구강 협점막하로 투여한 Midazolam의 효과에 관한 연구. 대한치과마취과학회지, 5:101-106, 2005.
  7. 박미경, 김윤희, 정상혁 등: Midazolam을 구강 점막하로 병용투여한 진정법의 안정성과 Houpt scale을 이용한 진정효과에 대한 연구. 대한치과마취과학회지, 6:103-112, 2006.
  8. AAPD: Guideline on the elective use of minimal, moderate, and deep sedation and general anesthesia for pediatric dental patients. Pediatr Dent, 27: Spec 110-118, 2006.
  9. 홍창의: 소아과학, 9판, 대한교과서, 서울, 20-53, 2007.
  10. Olkkola KT, Ahonen J : Midazolam and other benzodiazepines. Handb Exp Pharmacol, 182:335-360, 2008. https://doi.org/10.1007/978-3-540-74806-9_16
  11. Win NN, Fukayama H, Kohase H, Umino M: The different effects of intravenous propofol and midazolam sedation on hemodynamic and heart rate variability. Anesth Analg, 101:97-102, 2005. https://doi.org/10.1213/01.ANE.0000156204.89879.5C
  12. Walbergh EJ, Willis RJ, Eckhert J: Plasma concentrations of midazolam in children following intranasal administration. Anesthesiology, 74:233- 235, 1991. https://doi.org/10.1097/00000542-199102000-00007
  13. Rey E, Delaunay L, Pons G, et al. : Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol, 41:355-357, 1991. https://doi.org/10.1007/BF00314967
  14. Saint-Maurice C, Landais A, Delleur MM, et al. : The use of midazolam in diagnostic and short surgical procedures in children. Acta Anaesthesiol Scand, 92:39-41, 1990.
  15. Primosch RE, Gulemann M : Comparison of drop versus spray administration of intranasal midazolam in two and three-year-old children for dental sedation. Pediatr Dent, 27:401-408, 2005.

Cited by

  1. A Review of the Systemic Analysis Method on Dental Sedation for Children vol.42, pp.4, 2015, https://doi.org/10.5933/JKAPD.2015.42.4.331